Patent
Fluorescence quenching with immunological pairs in immunoassays
Reads0
Chats0
TLDR
In this article, the unknown and antibody specific for the ligand of interest to which is bound one of the F-Q pair, are combined in an aqueous buffered medium.Abstract:
Immunoassays employing antibodies and a fluorescer-quencher (F-Q) chromophoric pair, wherein one or both of the chromophoric pair are bonded to antibodies. Depending on the particular ligand of interest, various reagent combinations can be employed, where the amount of quenching is directly related to the amount of ligand present in the assay medium. In carrying out the assay, the unknown and antibody specific for the ligand of interest to which is bound one of the F-Q pair, are combined in an aqueous buffered medium. Depending on the protocol, different assay reagents are employed in the aqueous buffered medium: (1) ligand analog bonded to the other of the F-Q pair; (2) antibodies specific for the ligand to which is bound the other of the F-Q pair or; finally, (3) a combination of a plurality of ligands bonded together through linking groups to a hub molecule, usually a polymer, in combination with antibody bound to the other of the F-Q pair. The composition is irradiated with light at a wavelength, absorbed by the fluorescing molecule and the amount of fluorescence determined. By employing appropriate standards, the presence and amount of the ligand can be determined.read more
Citations
More filters
Patent
Immunometric assays using monoclonal antibodies
TL;DR: In this article, two-site or "sandwich" immunometric assay techniques for determination of the presence and/or concentration of antigenic substances in fluids using monoclonal antibodies are described and compared to conventional assays using polyclonal antibodies.
Patent
Nanoparticles having oligonucleotides attached thereto and uses therefor
Chad A. Mirkin,Robert L. Letsinger,Robert C. Mucic,James J. Storhoff,Robert Elghanian,Thomas Andrew Taton +5 more
TL;DR: In this paper, a method for detecting a nucleic acid is described. The method comprises contacting the nucleic acids with one or more types of particles having oligonucleotides attached thereto, and a detectable change (preferably a color change) is brought about as a result of the hybridization of the oligon nucleotides on the nanoparticles to the nucleus.
Patent
Detectably labeled dual conformation oligonucleotide probes, assays and kits
TL;DR: In this paper, the authors proposed a hybridization of the target and complement sequences to shift the probe to an open conformation, which is detectable due to reduced interaction of the label pair or by detecting a signal from a non-interactive label.
Patent
Methods and apparatuses for analyzing polynucleotide sequences
TL;DR: In this article, a high speed, high throughput analysis of polynucleotide sequences, and apparatuses with which to carry out the methods are provided in the invention of the algorithm.
Patent
Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
TL;DR: In this paper, a semiconductor nanocrystal compound is described capable of linking to an affinity molecule, which can be used to determine the presence of a detectable substance in a material.
References
More filters
Patent
Antibody steric hindrance immunoassay with two antibodies
TL;DR: In this paper, a novel immunoassay is provided, as well as particular reagents, for determining the presence of a ligand, where a Reagent is employed having at least two epitopes, one of the epitopes being common with the ligand and the other epitope being a foreign epitope.
Patent
Receptor assays of biologically active compounds employing biologically specific receptors
TL;DR: In this article, the authors proposed novel assays for biologically active substrates employing purified target receptors, including fluorescent and radiochemical assays, employing labeled receptor in one embodiment and labeled substrate in another.
Patent
Fluorometric system, method and test article
TL;DR: A fluorometric system to determine the kind and amount of substances derived from a biological fluid or tissue in which the substances to be detected (e.g., antigen, antibody, hormone or enzyme) are coated onto a substrate surface in fluorescent form is described in this paper.
Patent
Double receptor fluorescent immunoassay
TL;DR: In this paper, a method for determining qualitatively and quantitatively the presence of a wide variety of physiologically active organic compounds (ligand) is provided, which employs a reagent which involves bonding a compound having structural similarity to the compound to be determined (ligands analog) to a fluorescing compound.
Patent
Method and apparatus for angiotensin i determination
TL;DR: In this article, a radioimmunoassay of 125I Angiotensin I generated by the action of renin in incubated plasma samples is presented, where antibody-specific antibody is employed as the specific antibody, and 125I Antibody to Angio-I is used as the labeled antigen.